Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Vidaza® (azacitidine) – New indication
May 20, 2022 - The FDA approved Celgene’s Vidaza (azacitidine) injection for the treatment of pediatric patients aged 1 month and older with newly diagnosed juvenile myelomonocytic leukemia (JMML).
